Synonyms that are in the dictionary are marked in green. Synonyms that are not in the dictionary are marked in red.
Antonyms that are in the dictionary are marked in green. Antonyms that are not in the dictionary are marked in red.
According to Llewellyn, "The discovery of an ABC transporter gene within the pigment gene cluster was a particular surprise.
Source: https://phys.org/news/2023-02-gene-cluster-reshuffling-natural-sunscreen.html
According to Llewellyn, "The discovery of an ABC transporter gene within the pigment gene cluster was a particular surprise.
Source: https://phys.org/news/2023-02-gene-cluster-reshuffling-natural-sunscreen.html
Actually, many of them are being -- participating in the previous gene editing trials.
Although the details are unknown, his doctors suggested to the outlet that he is about to embark on some far more experimental procedures, including gene therapies.
Although this person would possess both a blue-eye gene and a brown-eye gene in their genotype, their phenotype may only acknowledge the dominant trait, making their eyes brown.
Source: https://www.buzzfeednews.com/article/sydneethompson/multiracial-identity-language
Although this person would possess both a blue-eye gene and a brown-eye gene in their genotype, their phenotype may only acknowledge the dominant trait, making their eyes brown.
Source: https://www.buzzfeednews.com/article/sydneethompson/multiracial-identity-language
And at the University of Toronto, neuroscientist David Hampson and his group tried introducing a smaller gene that would fit in a single AAV vector and compensate for the deficiency in an indirect way.
Source: https://www.discovermagazine.com/health/hope-for-haploinsufficiency-diseases
And even if you inherit a gene associated with cancer, that doesn’t mean you’re guaranteed to get it.
Source: https://www.bostonmagazine.com/health/2023/01/24/boston-cancer-breakthroughs/
And when you heard back from the people that you sent a message to at the NIH, kind of, how did you feel about the possibility of gene therapy when you first heard about it?
Source: https://www.nytimes.com/2023/12/05/opinion/sickle-cell-therapy-fda.html
And while Sanders' executive effort lacks the broad — if — legislative imprimatur of its Floridian cousin, it is undeniably a product of the same conservative gene pool.
An element called Tcn12 often landed within the sequence of a gene, potentially disrupting the gene’s function and possibly leading to drug resistance.
Angelman syndrome is caused by a loss of function in the UBE3A gene on the maternal 15th chromosome, according to the Foundation for Angelman Syndrome Therapeutics, the largest non-governmental funder of Angelman syndrome research.
Source: https://www.twincities.com/2023/02/12/angelman-syndrome-rosemount-family-seeks-cure/
Animal genetics is the branch of genetics that deals with the study of gene variation and inheritance in companion, domestic and wild animals is called as animal genetics.
As a mother of three who lacked the altruistic gene, and who were quite judgmental, I urged them to volunteer.
Source: https://www.dailycamera.com/2023/06/01/ask-amy-time-to-sell-a-gift-that-has-outlived-a-friendship/
BAP1 Cancer Syndrome, caused by inherited mutations of the BAP1 gene, was discovered by Carbone and his team at the in 2011.
Because the gene that controls the expression of interferon gamma is on the X chromosome, it "escapes X inactivation in females" — meaning "there's more of it in females compared to males."
But Lexeo’s IPO comes as a rival gene therapy developer sues the biotech, claiming its work employs stolen trade secrets.
Candidates include the inherited condition sickle cell anaemia, in which a single gene defect disrupts haemoglobin production with serious consequences for patients, who suffer anaemia because their bodies are starved of oxygen.
Cellectis has been utilizing gene editing technology for 23 years, and specifically focuses TALEN on for electroporation.
Source: https://investorplace.com/2023/01/7-crispr-stocks-with-the-best-long-term-potential/
CRISPR is on the cusp of potentially having the first FDA approved therapy using gene editing, CASGEVY (exa-cel) - the FDA rules on this on December 8, 2023.